The rno‐miR‐34 family is upregulated and targets ACSL1 in dimethylnitrosamine‐induced hepatic fibrosis in rats

No abstract is available for this paper.

• Publication year

  2011

• Venue

  The FEBS Journal

• Publication date

  2011-05-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1111/j.1742-4658.2011.08075.xPMID 21366874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis

  2011cited by this paper
• A potentially functional polymorphism in the promoter region of miR‐34b/c is associated with an increased risk for primary hepatocellular carcinoma

  2011cited by this paper
• MicroRNAs and the regulation of fibrosis

  2010cited by this paper
• Suppression of type I collagen production by microRNA-29b in cultured human stellate cells.

  2010cited by this paper
• MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.

  2010cited by this paper
• Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation.

  2010cited by this paper
• Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways

  2009cited by this paper
• The JAK and STAT family members of the mandarin fish Siniperca chuatsi: molecular cloning, tissues distribution and immunobiological activity.

  2009cited by this paper
• Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells

  2009cited by this paper
• Over‐expressed microRNA‐27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation

  2009cited by this paper
• Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells

  2009cited by this paper
• Emerging role of microRNAs in liver diseases.

  2009cited by this paper
• Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

  2008cited by this paper
• SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.

  2008cited by this paper
• Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.

  2008cited by this paper
• Immunoblotting conditions for human hemoglobin chains.

  2008cited by this paper
• Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

  2007cited by this paper
• Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans

  2007cited by this paper
• A microRNA component of the p53 tumour suppressor network

  2007cited by this paper
• The guardian's little helper: microRNAs in the p53 tumor suppressor network.

  2007cited by this paper
• Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest

  2007cited by this paper
• MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

  2007cited by this paper
• Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

  2007cited by this paper
• High‐density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats

  2007cited by this paper
• Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.

  2007cited by this paper
• LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

  2006cited by this paper
• Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement.

  2006cited by this paper
• Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis.

  2006cited by this paper
• Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis.

  2006cited by this paper
• Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets

  2006cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Polyunsaturated fatty acid regulation of genes of lipid metabolism.

  2005cited by this paper
• Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications

  2004cited by this paper
• Liver fibrosis

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• From gene networks to gene function.

  2003cited by this paper
• Intracellular signal transduction pathways activated by ceramide and its metabolites.

  2003cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis

  2001cited by this paper
• Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury*

  2000cited by this paper
• Effects of dietary polyunsaturated fatty acids and nucleotides on tissue fatty acid profiles of rats with carbon tetrachloride-induced liver damage.

  1999cited by this paper
• Search for a W{sup '} Boson via the Decay Mode W{sup '}{yields}{mu} {nu}{sub {mu}} in 1.8 TeV pp(bar sign) Collisions

  1999cited by this paper

• MicroRNAs in metabolic syndrome: Mechanisms, diagnosis, and therapy.

  2025cites this paper
• Hepatocyte delivery of miR-34b/c reduces hepatic stellate cell activation and improves liver fibrosis

  2025cites this paper
• Up-regulation of long non-coding RNA H19 ameliorates renal tubulointerstitial fibrosis by reducing lipid deposition and inflammatory response through regulation of the microRNA-130a-3p/long-chain acyl-CoA synthetase 1 axis

  2024cites this paper
• miR-34c-5p inhibited fibroblast proliferation, differentiation and epithelial-mesenchymal transition in benign airway stenosis via MDMX/p53 pathway

  2024cites this paper
• Advances in the regulation of adipogenesis and lipid metabolism by exosomal ncRNAs and their role in related metabolic diseases

  2023cites this paper
• The potential role of miRNAs and regulation of their expression in the development of mare endometrial fibrosis

  2023cites this paper
• Regulatory Roles of MicroRNAs in the Pathogenesis of Metabolic Syndrome

  2023cites this paper
• MicroRNA-34a: A Novel Therapeutic Target in Fibrosis

  2022cites this paper
• MicroRNA-34b-5p binds enhancer of zeste 2 to inhibit milk fat globule-EGF factor 8 expression, affecting liver fibrosis

  2022cites this paper
• Tanshinone IIA improves diabetes‐induced renal fibrosis by regulating the miR‐34‐5p/Notch1 axis

  2022cites this paper
• Liver Regeneration: Changes in Oxidative Stress, Immune System, Cytokines, and Epigenetic Modifications Associated with Aging

  2022cites this paper
• microRNA-34 Family: From Mechanism to Potential Applications.

  2022cites this paper
• Macrophage activation in the lung during the progression of nitrogen mustard induced injury is associated with histone modifications and altered miRNA expression.

  2021cites this paper
• The role of microRNA-34 family in Alzheimer's disease: a potential molecular link between neurodegeneration and metabolic disorders.

  2021cites this paper
• ACSL family: The regulatory mechanisms and therapeutic implications in cancer.

  2021cites this paper
• Roles of microRNAs in carbohydrate and lipid metabolism disorders and their therapeutic potential.

  2021cites this paper
• MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression

  2021cites this paper
• Comparative microRNA Transcriptomes in Domestic Goats Reveal Acclimatization to High Altitude

  2020cites this paper
• miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.

  2020cites this paper
• Integrative microRNA and mRNA expression profiling in acute aristolochic acid nephropathy in mice

  2020cites this paper
• miR-7-5p Promotes Hepatic Stellate Cell Activation by Targeting Fibroblast Growth Factor Receptor 4

  2020cites this paper
• Differentially expressed microRNAs, including a large microRNA cluster on chromosome 24, are associated with equine sarcoid and squamous cell carcinoma.

  2019cites this paper
• MIR 129 5-P AS A NONINVASIVE PROGNOSTIC BIOMARKER OF LIVER FIBROSIS IN HCV EGYPTIAN POPULATION

  2019cites this paper
• Molecular determinants of mesenchymal cell activation in fibroproliferative diseases

  2019cites this paper
• Downregulation of miR-152 contributes to the progression of liver fibrosis via targeting Gli3 in vivo and in vitro

  2019cites this paper
• miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling

  2019cites this paper
• Selection of reference genes for miRNA quantitative PCR and its application in miR-34a/Sirtuin-1 mediated energy metabolism in Megalobrama amblycephala

  2019cites this paper
• Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p.

  2019cites this paper
• Therapeutic effects of serum extracellular vesicles in liver fibrosis

  2018cites this paper
• The Role of microRNAs in the Gut-Liver Axis

  2018cites this paper
• The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity

  2018influential citation
• circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling

  2018cites this paper
• Effect of Training Intensity on Hepatic Steatosis and Expression of miRNAs and Target Genes in a High-fat Diet-induced Mice

  2018cites this paper
• In Vivo Analysis of miR-34a Regulated Glucose Metabolism Related Genes in Megalobrama amblycephala

  2018influential citation
• Bioinformatic prediction and analysis of glucolipid metabolic regulation by miR-34a in Megalobrama amblycephala

  2017cites this paper
• Maternal chromium restriction modulates miRNA profiles related to lipid metabolism disorder in mice offspring

  2017cites this paper
• miRNA-338-3p/CDK4 signaling pathway suppressed hepatic stellate cell activation and proliferation

  2017cites this paper
• The roles of microRNA families in hepatic fibrosis

  2017cites this paper
• Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis.

  2017cites this paper
• miR-378 reduces mesangial hypertrophy and kidney tubular fibrosis via MAPK signalling.

  2017cites this paper
• MicroRNA signatures associated with thioacetamide-induced liver fibrosis in mice

  2017cites this paper
• MicroRNAs and clinical implications in hepatocellular carcinoma

  2017cites this paper
• Genome-wide identification of novel ovarian-predominant miRNAs: new insights from the medaka (Oryzias latipes)

  2017cites this paper
• Identifying miRNA-mRNA regulation network of chronic pancreatitis based on the significant functional expression

  2017cites this paper
• Epithelial to mesenchymal transition in Cyclosporine A-induced rat gingival overgrowth.

  2017cites this paper
• Proteome-based identification of apolipoprotein A-IV as an early diagnostic biomarker in liver fibrosis

  2017cites this paper
• Role of miR-34a in TGF-β1- and Drug-Induced Epithelial-Mesenchymal Transition in Alveolar Type II Epithelial Cells.

  2017cites this paper
• Effects of Panax japonicus hypolipidemic compound on non-alcoholic fatty liver disease in mice and its mechanism

  2017cites this paper
• Clinical Application of MicroRNAs in Liver Diseases

  2017cites this paper
• MicroRNA profile analysis in the liver fibrotic tissues of chronic hepatitis B patients

  2017cites this paper
• miR-706 inhibits the oxidative stress-induced activation of PKCα/TAOK1 in liver fibrogenesis

  2016cites this paper
• Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

  2016cites this paper
• Polymeric Nanocarriers for Delivery of Small Molecules and miRNAs for the Treatment of Liver Fibrosis and Pancreatic Cancer

  2016cites this paper
•  MicroRNA-146b regulates hepatic stellate cell activation via targeting of KLF4.

  2016cites this paper
• A micro-RNA expression signature for human NAFLD progression

  2016cites this paper
• MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression

  2016cites this paper
• Role of microRNA in liver regeneration.

  2016cites this paper
• Cyclosporine A promotes cell proliferation, collagen and α-smooth muscle actin expressions in rat gingival fibroblasts by Smad3 activation and miR-29b suppression.

  2016cites this paper
• MicroRNA-146b regulates hepatic stellate cell activation via targeting of KLF4.

  2016cites this paper
• Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs

  2016cites this paper
• MicroRNA Expression Profiling in CCl4-Induced Liver Fibrosis of Mus musculus

  2016cites this paper
• MicroRNA: a connecting road between apoptosis and cholesterol metabolism

  2016cites this paper
• MicroRNA Bta-miR-181a regulates the biosynthesis of bovine milk fat by targeting ACSL1.

  2016cites this paper
• Familial adenomatous patients with desmoid tumours show increased expression of miR-34a in serum and high levels in tumours

  2016cites this paper
• Dynamic Expression of Novel MiRNA Candidates and MiRNA-34 Family Members in Early- to Mid-Gestational Fetal Keratinocytes Contributes to Scarless Wound Healing by Targeting the TGF-β Pathway

  2015cites this paper
• 3. Stellate cells

  2015cites this paper
• Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice

  2015cites this paper
• Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease

  2015cites this paper
• Functional and diagnostic role of microRNAs in Schistosoma mansoni infection

  2015cites this paper
• The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis.

  2015cites this paper
• Antihepatofibrotic Effects of Aqueous Extract of Prunella vulgaris on Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats

  2015cites this paper
• microRNA-34a and microRNA-34c promote the activation of human hepatic stellate cells by targeting peroxisome proliferator-activated receptor γ.

  2015cites this paper
• Roles of microRNAs in diseases of the human gastrointestinal tract

  2015cites this paper
• MicroRNA-34a Promotes Hepatic Stellate Cell Activation via Targeting ACSL1

  2015cites this paper
• Role of redoximiRs in fibrogenesis

  2015cites this paper
• Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis.

  2015cites this paper
• Epigenetic Modifications in Fibrotic Diseases: Implications for Pathogenesis and Pharmacological Targets

  2015cites this paper
• Review The p 53 / miR- 34 axis in development and disease

  2014influential citation
• Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease

  2014cites this paper
• MicroRNA in hepatic fibrosis and cirrhosis 1419 causing blood flow changes and the potential development of liver failure

  2014cites this paper
• The p53/miR-34 axis in development and disease.

  2014influential citation
• MicroRNAs Linking Cancer and Inflammation: Focus on Liver Cancer

  2014cites this paper
• TARGETED THERAPY FOR LIVER FIBROSIS AND CANCER

  2014influential citation
• Steatosis and Steatohepatitis: Complex Disorders

  2014cites this paper
• Research progress on the role of miRNAs in the regulation for NAFLD

  2014cites this paper
• Circulating MicroRNA Profiles Differ between Qi-Stagnation and Qi-Deficiency in Coronary Heart Disease Patients with Blood Stasis Syndrome

  2014cites this paper
• Overexpression of miR-126 Inhibits the Activation and Migration of HSCs through Targeting CRK

  2014cites this paper
• miR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction

  2014cites this paper
• P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy

  2014cites this paper
• Delivery and Targeting of miRNAs for Treating Liver Fibrosis

  2014cites this paper
• MicroRNA in hepatic fibrosis and cirrhosis.

  2014cites this paper
• MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4

  2014influential citation
• Suppression of collagen synthesis by Dicer gene silencing in hepatic stellate cells.

  2014cites this paper
• Deep sequencing analysis of microRNA expression in porcine serum-induced hepatic fibrosis rats.

  2014cites this paper
• Autophagy and microRNA dysregulation in liver diseases

  2014cites this paper
• MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma

  2013cites this paper
• Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer.

  2013cites this paper
• The role of miRNAs in animal models of liver fibrosis

  2013cites this paper
• RNAi in Liver Diseases

  2013cites this paper
• Dual Role of MicroRNAs in NAFLD

  2013influential citation